Genfit to conduct large liver drug trial despite setback

March 26 (Reuters) - French drugmaker Genfit SA said on Thursday it will begin a late stage trial later this year of its lead treatment for a liver-destroying condition, saying it failed a midstage trial in part due to the prevalence of patients with a mild form of the disease in the study.